Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Study Details page shows cosmetic/UI adjustments to layout with no changes to core study information such as eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:08:20.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Update includes a funding/status notice and a version bump to v3.2.0; the previous v3.1.0 reference was removed.
    Difference
    3%
    Check dated 2025-10-06T05:47:36.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:50.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    This is a minor update: the revision is updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No changes were made to core content, pricing, stock, or time-slot information.
    Difference
    0.2%
    Check dated 2025-09-14T20:02:22.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T16:59:24.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has added specific facility names and locations related to acute myeloid leukemia and myelodysplastic syndrome, while removing several previous location details and references to other diseases.
    Difference
    3%
    Check dated 2025-08-31T12:09:03.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.